Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014951 |
| CAS No | NA |
| Mol.F. | C19H19N7O4 |
| Mol.Wt. | 409.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014952 |
| CAS No | NA |
| Mol.F. | C19H20N6O3 |
| Mol.Wt. | 380.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014953 |
| CAS No | 2768787-11-5 |
| Mol.F. | C25H27N7O2 |
| Mol.Wt. | 475.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014954 |
| CAS No | NA |
| Mol.F. | C25H27N7O2 |
| Mol.Wt. | 457.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014955 |
| CAS No | NA |
| Mol.F. | C11H17N3O2 |
| Mol.Wt. | 223.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014956 |
| CAS No | 2826147-23-1 |
| Mol.F. | C4H6N2O3 |
| Mol.Wt. | 130.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014957 |
| CAS No | NA |
| Mol.F. | C4H6N2O3 |
| Mol.Wt. | 130.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014958 |
| CAS No | NA |
| Mol.F. | C4H6N2O3 |
| Mol.Wt. | 130.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014959 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014960 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014961 |
| CAS No | 77817-40-4 |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. | 180.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014962 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014963 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014964 |
| CAS No | NA |
| Mol.F. | C5H11N3O |
| Mol.Wt. | 129.16 |
| INV STATUS | In Stock |
| CAT No | SRC-N014965 |
| CAS No | NA |
| Mol.F. | C20H22N2O2 |
| Mol.Wt. | 322.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014966 |
| CAS No | NA |
| Mol.F. | C9H10N2O3 |
| Mol.Wt. | 194.2 g/mol |
| INV STATUS | In Stock |